II Workshop do Consórcio Cure Group 4
II Cure Group 4 Consortium Workshop: Clinical trials are coming! The most important highlight of the Consortium’s second in-person workshop is the announcement…
Global stage
On June 2, 2023, MBI founder Fernando Goldsztein spoke at a summit of entrepreneurs hosted by MIT, the MBA program where Fernando studied…
First in-person workshop for researchers
“We hope to have paved the way for treatment of this disease,” says Roger Packer of Children’s National Hospital in Washington DC (USA)…
Taking the lead against childhood brain cancer
In 2002, Fernando Goldsztein entered the MBA program at the Massachusetts Institute of Technology (MIT) to broaden his vision of management….